BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence
暂无分享,去创建一个
B. Conklin | E. Hsiao | S. Yamanaka | Y. Matsumoto | J. Toguchida | K. Tomoda | K. Nishimura | I. Asaka | C. Schlieve | Y. Hayashi | Ayako Nagahashi | M. Ikeya | A. Fukuda | K. Hisatake | Salma Sami | M. Lancero | Koyori Yano | Trieu Nguyen | Isao Asaka
[1] D. Srivastava,et al. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling , 2016, Stem Cell Research & Therapy.
[2] Y. Matsumoto,et al. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva , 2015, Proceedings of the National Academy of Sciences.
[3] Lily Huang,et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A , 2015, Science Translational Medicine.
[4] Y. Matsumoto,et al. New Protocol to Optimize iPS Cells for Genome Analysis of Fibrodysplasia Ossificans Progressiva , 2015, Stem cells.
[5] B. Conklin,et al. Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation , 2013, Orphanet Journal of Rare Diseases.
[6] M. Hamasaki,et al. Pathogenic Mutation of ALK2 Inhibits Induced Pluripotent Stem Cell Reprogramming and Maintenance: Mechanisms of Reprogramming and Strategy for Drug Identification , 2012, Stem cells.
[7] David A. Williams,et al. Overcoming reprogramming resistance of Fanconi anemia cells. , 2012, Blood.
[8] R. Benezra,et al. Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression. , 2012, Stem cells and development.
[9] G. Sapkota,et al. The specificities of small molecule inhibitors of the TGFß and BMP pathways. , 2011, Cellular signalling.
[10] J. Bartek,et al. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16ink4a , 2011, Cell cycle.
[11] J. Wrana,et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. , 2010, Cell stem cell.
[12] Jialiang Liang,et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.
[13] H. Ryoo,et al. Molecular Consequences of the ACVR1R206H Mutation of Fibrodysplasia Ossificans Progressiva* , 2010, The Journal of Biological Chemistry.
[14] M. Goumans,et al. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP‐induced osteoblast differentiation and bone formation , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] R. Kalluri,et al. Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.
[16] David R. Liu,et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. , 2009, Cell stem cell.
[17] Shawn C. Little,et al. The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. , 2009, The Journal of clinical investigation.
[18] G. Daley,et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells , 2009, Nature Biotechnology.
[19] Sheng Ding,et al. A chemical platform for improved induction of human iPSCs , 2009, Nature Methods.
[20] C. Pereira,et al. Senescence impairs successful reprogramming to pluripotent stem cells. , 2009, Genes & development.
[21] M. Blasco,et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.
[22] J. Utikal,et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells , 2009, Nature.
[23] T. Ichisaka,et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.
[24] Shinya Yamanaka,et al. Elite and stochastic models for induced pluripotent stem cell generation , 2009, Nature.
[25] A. Consiglio,et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.
[26] Randall T Peterson,et al. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[27] Charles C Hong,et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.
[28] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[29] T. Ichisaka,et al. Generation of germline-competent induced pluripotent stem cells , 2007, Nature.
[30] G. Keller,et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. , 2007, Blood.
[31] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[32] In Ho Choi,et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva , 2006, Nature Genetics.
[33] Ariel J. Levine,et al. TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells , 2005 .
[34] J. Thomson,et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells , 2005, Nature Methods.
[35] Ariel J. Levine,et al. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. , 2005, Development.
[36] Jing Wang,et al. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Nichols,et al. BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3 , 2003, Cell.
[38] Lisheng Wang,et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. , 2003, Blood.
[39] K. Miyazono,et al. Id: A Target of BMP Signaling , 2002, Science's STKE.
[40] P. ten Dijke,et al. Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.
[41] J. Massagué,et al. Direct Binding of Smad1 and Smad4 to Two Distinct Motifs Mediates Bone Morphogenetic Protein-specific Transcriptional Activation ofId1 Gene* , 2002, The Journal of Biological Chemistry.
[42] C. Murre,et al. The regulation and function of the Id proteins in lymphocyte development , 2001, Oncogene.
[43] E. Hara,et al. Id proteins in cell cycle control and cellular senescence , 2001, Oncogene.
[44] S. Rafii,et al. The Id proteins and angiogenesis , 2001, Oncogene.
[45] D. Carrasco,et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis , 2001, Nature.
[46] R. Alani,et al. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[47] G. Peters,et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence , 2001, Nature.
[48] D. Melton,et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Diaz,et al. Id-1 delays senescence but does not immortalize keratinocytes. , 2000, The Journal of biological chemistry.
[50] W. Gerald,et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.
[51] A. Nordheim,et al. Id Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells* , 1999, The Journal of Biological Chemistry.
[52] J. Massagué,et al. A human Mad protein acting as a BMP-regulated transcriptional activator , 1996, Nature.
[53] Philip R. Cohen,et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.